The country’s new national research programme, called Advancing 3R – Animals, Research and Society, promotes scientific projects that contribute to improving, reducing or replacing animal experiments in Swiss research.
Among its recent initiatives is a joint project of the aquatic research institute Eawag and the University of Utrecht. The project, which is has received almost CHF 1 million in funding, is scheduled to run for four years and has the objective of replacing fish-based animal testing with a combination of in-vitro tests and computer models.
Under the leadership of Kristin Schirmer, Eawag has been working for many years to replace animal experiments on fish with in-vitro methods. These are toxicity tests based on fish cells grown in the laboratory. These cells can be used to study how toxic certain chemicals are to fish. This is an important result, which determines, for example, whether new substances can be approved for the market.
A test developed by Schirmer’s team based on rainbow trout gill cells was released last year by the Organisation for Economic Cooperation and Development (OECD) as the latest guideline in the field of environmental toxicology.
“We chose gill cells because it is the gills that first come into contact with chemicals in water due to their large surface area in the fish,” explained Schirmer in a press release. “So by observing how the gill cells are damaged by a chemical, we can predict how that chemical would affect a living fish.”
The virtual fish makes a comprehensive view possible
However, an even more comprehensive picture of how chemicals can affect the fish can only be obtained by considering other important organs in addition to the gills. The researchers are now pursuing this objective and are working on tests based on the intestine or nerve cells of rainbow trout. A look at the molecular level – ie at proteins or RNA molecules – will help to complete the picture.
As Ksenia Groh, who is the research group leader, explained: “Our vision is that the data from the in-vitro tests on cells of all major organs will flow into a single computer model, the virtual fish.”
This should enable detailed and well-founded statements to be made on how chemicals affect fish – without having to resort to experiments on living fish.
Cooperation with partners in practice
An important part of the project is the involvement of the chemical industry as well as the authorities responsible for the approval of new chemicals.
“We want to develop the virtual fish together with them in order to align the process from development to application at the regulatory level to the effective needs – which in the case of the gill test took twelve years – and thus speed it up,” said Groh.
Prof Bernhard Truffer, an expert in the field of technical innovations, who is also involved in the project, noted: “Early involvement of the players is important so that the requirements posed by later implementation can already be taken into account during development of the methods. In this way, animal testing can be replaced more quickly in practice.”
Colette vom Berg, who is involved in the project as a research group leader, summarised: “For some time now, Eawag has been doing research with many partners to develop tests that make experiments on living fish unnecessary. With this great project, we have the opportunity to combine different approaches and close gaps.”